Onconetix, Inc. Annual Operating Income (Loss) in USD from 2021 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Onconetix, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2021 to 2023.
  • Onconetix, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$2.65M, a 41% increase year-over-year.
  • Onconetix, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$49.4M, a 187% decline year-over-year.
  • Onconetix, Inc. annual Operating Income (Loss) for 2023 was -$36M, a 167% decline from 2022.
  • Onconetix, Inc. annual Operating Income (Loss) for 2022 was -$13.5M, a 294% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$36M -$22.6M -167% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-11
2022 -$13.5M -$10.1M -294% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-11
2021 -$3.42M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.